Literature DB >> 8192712

Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.

S K Kulick1, D A Kramer.   

Abstract

Hyperammonemia has been described as a complication of valproic acid therapy but may often be overlooked as a cause of lethargy in the postictal patient who presents to the emergency department. We present the case of a postictal patient with lethargy, hyperammonemia, otherwise normal liver function tests, and a therapeutic valproic acid level. Based on our experience and on previously published data, serum ammonia levels appear to be indicated in all ED patients on valproic acid therapy who present with altered mental status. To the best of our knowledge, this has not been reported previously in the emergency medicine literature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8192712     DOI: 10.1016/s0196-0644(05)81955-9

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  3 in total

Review 1.  Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.

Authors:  Estee Chan; Fiona McQueen
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

2.  Valproate disturbs the balance between branched and aromatic amino acids in rats.

Authors:  Piotr Maciejak; Janusz Szyndler; Karolina Kołosowska; Danuta Turzyńska; Alicja Sobolewska; Jerzy Walkowiak; Adam Płaźnik
Journal:  Neurotox Res       Date:  2013-11-19       Impact factor: 3.911

3.  Association between the blood concentrations of ammonia and carnitine/amino acid of schizophrenic patients treated with valproic acid.

Authors:  Masazumi Ando; Hideaki Amayasu; Takahiro Itai; Hisahiro Yoshida
Journal:  Biopsychosoc Med       Date:  2017-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.